Nouraee Cyrus M, Uzlik Rachel M, Wyard Gary E, Stone McGaver Rebecca, Ericksen Dean M, Moon Ryan A, Giveans M Russell
Orthopedic Surgery Research, Revo Health, Golden Valley, USA.
Quality, Revo Health, Golden Valley, USA.
Cureus. 2021 Apr 6;13(4):e14332. doi: 10.7759/cureus.14332.
Background During the last several decades, the opioid epidemic throughout the United States has been recognized as an increasing problem. The aim of this study was to identify and implement processes throughout a single private orthopedic practice and managed ambulatory surgery centers to reduce opioid prescription pill quantity and strength, while also reducing consumption. Methodology A baseline assessment along with the development of four separate phases was implemented. Data collection included type, dosage, and quantity of opioids prescribed after elective outpatient procedures as well as patient interviews/surveys within two weeks after surgery. Quality improvement implementation included: (a) presentations on opioid prescribing at an individual physician level, (b) internal prescription guidelines, (c) required Prescription Monitoring Program registration, and (d) patient narcotic education pamphlets after surgery. The average opioids prescribed and consumed were compared between different time points. Results Analysis revealed a highly statistically significant decrease in both pills and morphine equivalent units (MEUs) prescribed (p < 0.001, p < 0.001) between the baseline assessment and four subsequent phases, as well as consumed (p < 0.001, p < 0.001) between phases one through four. Even though patients were consuming less pills and MEUs than they were prescribed on average across all phases, overall pain levels increased between phases one through four (p < 0.001), and overall satisfaction of pain control decreased between phases two through four (p < 0.001). Conclusions Over a 24-month time frame, a single private orthopedic practice set a goal of reducing prescribing habits and with successful implementation of various measures, a significant reduction in opioids prescribed and consumed was accomplished. Interestingly, pain level and satisfaction of pain control worsened even though patients were continuing to be prescribed more opioids on average than they were consuming. Therefore, it may be normal to see these results when attempting to set the expectation for some level of pain and reduced consumption of opioid medications post-operatively. Overall, these results can be useful to healthcare administrators and surgeons looking for ways to combat the opioid epidemic.
背景 在过去几十年里,美国全国范围内的阿片类药物泛滥已被视为一个日益严重的问题。本研究的目的是在一家私立骨科诊所和管理式门诊手术中心确定并实施相关流程,以减少阿片类处方药的数量和强度,同时减少其消耗量。方法 实施了一次基线评估以及四个不同阶段的制定。数据收集包括择期门诊手术后开具的阿片类药物的类型、剂量和数量,以及术后两周内的患者访谈/调查。质量改进措施包括:(a) 在个体医生层面进行阿片类药物处方的讲座,(b) 内部处方指南,(c) 要求注册处方监测计划,以及(d) 术后患者麻醉教育手册。比较了不同时间点开具和消耗的阿片类药物的平均量。结果 分析显示,在基线评估与随后的四个阶段之间,开具的药丸数量和吗啡当量单位(MEUs)均有极显著的统计学下降(p < 0.001,p < 0.001),在第一阶段至第四阶段之间消耗的也有极显著下降(p < 0.001,p < 0.001)。尽管在所有阶段患者平均消耗的药丸和MEUs比开具的少,但在第一阶段至第四阶段之间总体疼痛水平有所上升(p < 0.001),在第二阶段至第四阶段之间疼痛控制的总体满意度有所下降(p < 0.001)。结论 在24个月的时间框架内,一家私立骨科诊所设定了减少处方习惯的目标,并成功实施了各种措施,开具和消耗的阿片类药物显著减少。有趣的是,尽管患者平均继续被开具的阿片类药物比消耗的多,但疼痛水平和疼痛控制满意度却恶化了。因此,在试图设定术后一定程度疼痛和减少阿片类药物消耗的预期时,出现这些结果可能是正常的。总体而言,这些结果对于寻求应对阿片类药物泛滥方法的医疗管理人员和外科医生可能有用。